Thomas Finnerty - Feb 9, 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, Human Resources
Signature
/s/ Thomas Finnerty
Stock symbol
ANIK
Transactions as of
Feb 9, 2022
Transactions value $
-$96,737
Form type
4
Date filed
2/11/2022, 05:28 PM
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +10.1K +86.53% $0.00 21.8K Feb 9, 2022 Direct F1
transaction ANIK Common Stock Tax liability -$96.7K -3.15K -14.43% $30.72 18.7K Feb 9, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Performance Share Units ("PSUs") granted on February 26, 2019, and that the Compensation Committee of the Board of Directors determined on February 9, 2022 were earned. The PSUs vested in full on February 9, 2022 and were settled in shares of the Company's common stock on a one-for-one basis.
F2 Reflects an aggregate of 3,149 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to PSUs that vested on February 9, 2022.
F3 Reflects the closing price of the ANIK common stock on February 9, 2022, the trading day on which the vesting of PSUs gave rise to tax withholding obligations.